Hiroyuki Kobayashi

Summary

Affiliation: Kyorin University
Country: Japan

Publications

  1. ncbi Airway biofilm disease
    H Kobayashi
    First Department of Internal Medicine, Kyorin University School of Medicine, 6 20 2 Sinkawa, Mitaka, 181 0004, Tokyo, Japan
    Int J Antimicrob Agents 17:351-6. 2001
  2. ncbi Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections
    Hiroyuki Kobayashi
    First Department of Internal Medicine, Kyorin University School of Medicine, Shinkawa, Mitaka, Tokyo, Japan
    Treat Respir Med 4:241-53. 2005
  3. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 55:537-67. 2002
  4. ncbi Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis
    Kyong Ran Peck
    Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Chemotherapy 49:189-93. 2003
  5. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 56:365-95. 2003
  6. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 57:213-45. 2004
  7. ncbi Prospective study of antibiotic protocols for managing surgical site infections in children
    Satoko Ichikawa
    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo 113 8421, Japan
    J Pediatr Surg 42:1002-7; discussion 1007. 2007

Collaborators

  • Y Hirakata
  • Toyoko Oguri
  • Shin Kawai
  • S Kohno
  • K Yanagihara
  • Jae Hoon Song
  • Sook In Jung
  • K Hiramatsu
  • Kaoru Shimada
  • Nobuyuki Kobayashi
  • Hiroshi Inoue
  • Hiroko Inagawa
  • Junichi Matsuda
  • Midori Sumitomo
  • Hideo Ikemoto
  • Masakazu Tosaka
  • Takeshi Mori
  • Kouichiro Kudo
  • Tatsuo Nakatani
  • Yasuo Karasawa
  • Moritaka Suga
  • Yoshihito Niki
  • Jun Igari
  • Hiroshi Yokouchi
  • Shinji Okada
  • Akira Suwabe
  • Masaru Nasu
  • Kunio Nakano
  • Fumitake Gejyo
  • Masahiko Okada
  • Yasutoshi Suzuki
  • Kouichiro Nakata
  • Nobuko Kitamura
  • Toshiharu Matsushima
  • Nobuki Aoki
  • Toshihide Nakadate
  • Satoko Ichikawa
  • Hajime Goto
  • Makoto Yamamoto
  • Kyong Ran Peck
  • Tadao Nakano
  • Kazunori Tomono
  • Hisami Konosaki
  • Tadao Kinoshita
  • Masaaki Arakawa
  • Shiho Aoki
  • Akira Ito
  • Kenichi Igarashi
  • Tsugio Terai
  • Hiroyuki Nagai
  • Isao Ohno
  • Katsutoshi Hayashi
  • Ritsuko Obata
  • Yoshitsugu Miyazaki
  • Mihoko Ishihara
  • Geoffrey J Lane
  • Kengo Warabi
  • Yoshifumi Kato
  • Tadaharu Okazaki
  • Eiichi Inada
  • Satoshi Hori
  • Atsuyuki Yamataka
  • Tsukasa Tanaka
  • Yoshitugu Miyazaki
  • Hidenori Takeda
  • Yugo Ashino
  • Won Sup Oh
  • Yeon-Sook Kim
  • Ji Young Lee
  • Shin Woo Kim
  • Joung Hwa Jin
  • Yeon Sook Kim
  • Sungmin Kim
  • Satoshi Takayasu

Detail Information

Publications7

  1. ncbi Airway biofilm disease
    H Kobayashi
    First Department of Internal Medicine, Kyorin University School of Medicine, 6 20 2 Sinkawa, Mitaka, 181 0004, Tokyo, Japan
    Int J Antimicrob Agents 17:351-6. 2001
    ....
  2. ncbi Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections
    Hiroyuki Kobayashi
    First Department of Internal Medicine, Kyorin University School of Medicine, Shinkawa, Mitaka, Tokyo, Japan
    Treat Respir Med 4:241-53. 2005
    ..aeruginosa. These anti-biofilm actions of macrolides may represent their basic mechanisms of action on airway biofilm disease...
  3. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 55:537-67. 2002
    ..In the patients treated with aminoglycosides, macrolides, and quinolones, P. aeruginosa was most frequently isolated (33.3 to 40.0%)...
  4. ncbi Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis
    Kyong Ran Peck
    Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Chemotherapy 49:189-93. 2003
    ..This study was performed to evaluate the interaction of erythromycin or rifampin with vancomycin against Staphylococcus epidermidis biofilms...
  5. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2001)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 56:365-95. 2003
    ..aureus and P. aeruginosa. From the patients who had already treated with macrolides, S. pneumoniae was the most frequently isolated while S. aureus was the most frequently isolated from the patients pre-treated with quinolones...
  6. ncbi [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)]
    Kaoru Shimada
    Tokyo Senbai Hospital
    Jpn J Antibiot 57:213-45. 2004
    ..aeruginosa was relatively frequently isolated from the patients pretreated with cephems or macrolides and H. influenzae was relatively frequently isolated from the patients pretreated with penicillins...
  7. ncbi Prospective study of antibiotic protocols for managing surgical site infections in children
    Satoko Ichikawa
    Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo 113 8421, Japan
    J Pediatr Surg 42:1002-7; discussion 1007. 2007
    ..We adopted antibiotic (Ab) protocols for managing surgical site infections in children and assessed their effectiveness...